NCT04627948View on ClinicalTrials.gov

STHLM3 AS NorDCaP - a Followup Study of Men on Active Surveillance of Prostate Cancer

CompletedOBSERVATIONAL

Enrollment

199

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

July 1, 2024

Study Completion Date

July 1, 2024

Conditions

Prostate Cancer

Interventions

DIAGNOSTIC_TEST

Stockholm3 test

Diagnostic test: Stockholm3-test. Men from the study sites, diagnosed with prostate cancer and currently on AS and planned for rebiopsies will be invited to the study.

Trial Locations (1)

17177

Karolinska Institutet, Stockholm

All Listed Sponsors

collaborator

Helse Stavanger HF

OTHER_GOV

collaborator

University of Aarhus

OTHER

collaborator

Mehiläinen, Finland

UNKNOWN

collaborator

Capio Sankt Görans Hospital

OTHER

lead

Karolinska Institutet

OTHER

NCT04627948 - STHLM3 AS NorDCaP - a Followup Study of Men on Active Surveillance of Prostate Cancer | Biotech Hunter | Biotech Hunter